Research brief · Metabolic
Liraglutide
Short-acting GLP-1 reference compound for daily-exposure research models.
Class
GLP-1 receptor agonist
Half-life
~13 h
Studied in
Glucose homeostasis, satiety pathways.
What it is
Liraglutide is a once-daily GLP-1 analogue with a palmitoyl side chain that enables reversible albumin binding. It is a well-characterised reference compound in GLP-1 signaling research.
Mechanism studied
Acylated GLP-1 analogue with albumin binding for extended action.
Research notes
- Useful as a control alongside long-acting GLP-1 analogues.
Before sourcing any material
- Confirm a lot-matched third-party certificate of analysis (HPLC purity and mass-spectrometry identity).
- Check the stated peptide content per vial, not just the gross vial mass.
- Plan reconstitution volumes first so the vial size matches your protocol.
- Verify what is lawful in your jurisdiction — these are in-vitro research reagents, not medicines.